Prolactinoma - which patients react favorably to cabergoline medication?

Abstract

Objective. Prolactinoma, as a common endocrine disorder and the most frequent type of pituitary tumor, acts primarily as a suppressor on the gonadal functions. It is generally successfully treated with dopamine agonists; however, treatment resistance still remains in an unneglectable ratio. In this study, we aimed to identify factors, which may play a role in the treatment response.

Keywords

• prolactinoma
• pituitary
• endocrinology